mequinol
Selected indexed studies
- Treatment of Solar Lentigines: A Systematic Review of Clinical Trials. (J Cosmet Dermatol, 2025) [PMID:40145274]
- Mequinol 2%/tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literature. (Cutis, 2008) [PMID:18441773]
- Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. (J Clin Aesthet Dermatol, 2010) [PMID:20725554]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Treatment of Solar Lentigines: A Systematic Review of Clinical Trials. (2025) pubmed
- Mequinol 2%/tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literature. (2008) pubmed
- Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. (2010) pubmed
- Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines. (2004) pubmed
- The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies. (2000) pubmed
- Depigmentation Therapies for Vitiligo. (2017) pubmed
- Development and evaluation of kinetic spectrophotometric assays for horseradish peroxidase by catalytic coupling of paraphenylenediamine and mequinol. (2009) pubmed
- The combination of 2% 4-hydroxyanisole (mequinol) and 0.01% tretinoin effectively improves the appearance of solar lentigines in ethnic groups. (2006) pubmed
- Percutaneous absorption of [3H]tretinoin and systemic exposure to mequinol after dermal application of 2% mequinol/0.01% [3H]tretinoin (Solagé) solution in healthy volunteers. (1999) pubmed
- Safety and efficacy of combined use of 4-hydroxyanisole (mequinol) 2%/tretinoin 0.01% solution and sunscreen in solar lentigines. (2004) pubmed